Sharon A. Spencer

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

Advanced Head, Neck Cancer, Radiation Therapy +9

Chemoradiotherapy of Locally Advanced Esophageal Cancer

Jay S. Cooper, Matthew Guo, Arnold Herskovic et al. · JAMA · 1999 · 1.9K citations

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu, Thomas F. Pajak, Andy Trotti et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.4K citations

Radiation Medicine, Accelerated Fractionation, Radiation Therapy +10

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.2K citations

Radiation Therapy, Medicine, Nasopharyngeal Cancer +8

Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer

Maura L. Gillison, Qiang Zhang, Richard C. Jordan et al. · Journal of Clinical Oncology · 2012 · 480 citations · Full text